Literature DB >> 9884400

Evaluation of platelet membrane glycoproteins in coronary artery disease : consequences for diagnosis and therapy

.   

Abstract

Entities:  

Year:  1999        PMID： 9884400     DOI： 10.1161/01.cir.99.1.e1

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  16 in total

Review 1.  Comparative pharmacology of GP IIb/IIIa antagonists.

Authors:  Karsten Schrör; Artur-Aron Weber
Journal:  J Thromb Thrombolysis       Date:  2003-04       Impact factor: 2.300

Review 2.  Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.

Authors:  Giuseppe De Luca; Stefano Savonitto; Arnoud W J van't Hof; Harry Suryapranata
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

3.  Deubiquitinases Modulate Platelet Proteome Ubiquitination, Aggregation, and Thrombosis.

Authors:  Nilaksh Gupta; Wei Li; Thomas M McIntyre
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-15       Impact factor: 8.311

4.  [Antiplatelet therapy in acute coronary syndrome. Prehospital phase: nothing, aspirin or what?].

Authors:  T Bauer; C Hamm
Journal:  Herz       Date:  2014-11       Impact factor: 1.443

5.  Glycemia, triglycerides and disease severity are best associated with higher platelet activity in patients with stable coronary artery disease.

Authors:  Pavel P Osmancik; Frantisek Bednar; Heidi Móciková
Journal:  J Thromb Thrombolysis       Date:  2007-02-17       Impact factor: 2.300

6.  An ultrasound contrast agent targeted to P-selectin detects activated platelets at supra-arterial shear flow conditions.

Authors:  Felix Guenther; Constantin von zur Muhlen; Elisa A Ferrante; Sebastian Grundmann; Christoph Bode; Alexander L Klibanov
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

Review 7.  Platelet glycoprotein IIb/IIIa receptor antagonists and coronary artery disease.

Authors:  P Nguyen-Ho; N M Lakkis
Journal:  Curr Atheroscler Rep       Date:  2001-03       Impact factor: 5.113

8.  Effect of eptifibatide for acute coronary syndromes: rapid versus late administration--therapeutic yield on platelets (The EARLY Platelet Substudy).

Authors:  Paul A Gurbel; Brian Galbut; Kevin P Bliden; Raymond D Bahr; Matthew T Roe; Victor L Serebruany; W Brian Gibler; Robert H Christenson; E Magnus Ohman
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

Review 9.  Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction.

Authors:  Todd J Anderson
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

10.  Combined blockade of ADP receptors and PI3-kinase p110β fully prevents platelet and leukocyte activation during hypothermic extracorporeal circulation.

Authors:  Stefanie Krajewski; Julia Kurz; Tobias Geisler; Karlheinz Peter; Hans Peter Wendel; Andreas Straub
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.